Xilio Therapeutics (XLO) Revenue (2024 - 2026)
Xilio Therapeutics (XLO) posted Revenue of $12.6 million for Q1 2026, down 7.58% sequentially from $13.7 million in Q4 2025, and up 331.67% YoY from $2.9 million in Q1 2025.
Xilio Therapeutics (XLO) Revenue (2024 - 2026) Analysis & Trends
Xilio Therapeutics has reported Revenue for 3 years, with the latest figure at $12.6 million in Q1 2026.
- Quarterly Revenue rose 331.67% year-over-year to $12.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53.5 million (up 476.71% YoY) and the FY2025 annual result came in at $43.8 million, up 589.88% from the prior year.
- Revenue retreated to $12.6 million in Q1 2026 per XLO's latest filing, from $13.7 million in the prior quarter.
- Over five years, Revenue peaked at $19.1 million in Q3 2025 and troughed at $1.7 million in Q4 2024.
- A 3-year average of $7.8 million and a median of $5.5 million in 2025 frame the typical range for Revenue.
- The widest YoY moves for Revenue: up 742.51% in 2025, down 242.98% in 2025.
- Over 3 years, Revenue stood at $1.7 million in 2024, then jumped by 693.85% to $13.7 million in 2025, then fell by 7.58% to $12.6 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $12.6 million, $13.7 million, and $19.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 65.11 Bn | 59.92 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 55.73 Bn | 50.59 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | 674.14 Mn |
| 10 | Xilio Therapeutics | 178.33 Mn | 42.29 Mn | - | 18.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.69 Mn |
| Mar 31, 2026 | 12.65 Mn |
| Dec 31, 2025 | 13.69 Mn |
| Sep 30, 2025 | 19.07 Mn |
| Jun 30, 2025 | 8.08 Mn |
| Mar 31, 2025 | 2.93 Mn |
| Dec 31, 2024 | 1.72 Mn |
| Sep 30, 2024 | 2.26 Mn |
| Jun 30, 2024 | 2.36 Mn |